Indian biopharma company Biocon reported third-quarter revenue on Thursday that fell about 3% when compared with the ...

We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...

Swiss pharma giant Roche Holding AG RHHBY posted better-than-expected 2024 results and provided an encouraging outlook for ...

Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at Mayo Clinic, suggests that medical providers can reduce patient ...

ITM's lutetium-containing therapy extended progression-free survival versus everolimus in patients with a specific kind of ...

Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...

Oct. 7, 2024 — Researchers have discovered a natural immune mechanism in mice that stops escaped cancer cells from developing into tumors elsewhere in the ... Drug Improves Effectiveness of ...

Heartburn and acid reflux are common during chemotherapy ("chemo"), caused by cancer drugs subsequently attacking cells of the stomach and esophagus (feeding tube). Symptoms can flare immediately ...

The EMA recommended the highest number of approvals in the last 15 years in 2024, giving the nod to 114 drugs. That is amongst the highest number in the 30 years of the agency’s existence, said ...

So, Who Benefits From New Cancer Drugs? By Dennis Thompson HealthDay Reporter THURSDAY, Jan. 16, 2025 (HealthDay News) -- Cutting-edge targeted therapies are pushing back the line between life and ...

The synthetic dye has been linked to cancer in animal studies and was banned more than 30 years ago in cosmetics and topical drugs. Experts say the FDA’s move is a step forward in improving ...

The investigational drug, called PMD-026, is currently in phase 2 clinical trials for the treatment of breast cancer. Researchers at Washington University School of Medicine in St. Louis, MO, have ...